Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Isoflavones | 2 | 2023 | 88 | 1.570 |
Why?
|
| Soybean Proteins | 3 | 2024 | 162 | 1.100 |
Why?
|
| Influenza A virus | 3 | 2011 | 17 | 0.890 |
Why?
|
| Hepatitis | 1 | 2024 | 20 | 0.880 |
Why?
|
| Acute-Phase Proteins | 1 | 2024 | 24 | 0.870 |
Why?
|
| Lipopolysaccharides | 2 | 2024 | 207 | 0.810 |
Why?
|
| Membrane Glycoproteins | 1 | 2024 | 244 | 0.790 |
Why?
|
| Fatty Liver | 1 | 2023 | 142 | 0.770 |
Why?
|
| Carrier Proteins | 1 | 2024 | 326 | 0.760 |
Why?
|
| Virus Replication | 3 | 2012 | 150 | 0.700 |
Why?
|
| Rats, Zucker | 3 | 2024 | 73 | 0.630 |
Why?
|
| Orthomyxoviridae Infections | 2 | 2007 | 4 | 0.540 |
Why?
|
| Rats | 5 | 2024 | 3202 | 0.490 |
Why?
|
| Seoul virus | 2 | 2012 | 2 | 0.480 |
Why?
|
| Tumor Necrosis Factor-alpha | 3 | 2024 | 397 | 0.420 |
Why?
|
| Macrophages, Alveolar | 1 | 2012 | 30 | 0.380 |
Why?
|
| T-Lymphocytes, Regulatory | 1 | 2012 | 84 | 0.380 |
Why?
|
| Intracellular Space | 1 | 2011 | 24 | 0.360 |
Why?
|
| Amino Acid Substitution | 1 | 2011 | 82 | 0.360 |
Why?
|
| Obesity | 3 | 2024 | 1162 | 0.350 |
Why?
|
| Viral Nonstructural Proteins | 1 | 2011 | 61 | 0.340 |
Why?
|
| Animals | 8 | 2024 | 13523 | 0.340 |
Why?
|
| Endothelial Cells | 1 | 2012 | 283 | 0.340 |
Why?
|
| Influenza, Human | 1 | 2011 | 84 | 0.330 |
Why?
|
| Cardiovascular Diseases | 2 | 2024 | 486 | 0.280 |
Why?
|
| Selenium | 1 | 2007 | 7 | 0.270 |
Why?
|
| Ascorbic Acid Deficiency | 1 | 2006 | 1 | 0.270 |
Why?
|
| L-Gulonolactone Oxidase | 1 | 2006 | 1 | 0.270 |
Why?
|
| Male | 11 | 2024 | 26696 | 0.260 |
Why?
|
| Lung | 2 | 2007 | 502 | 0.250 |
Why?
|
| Hepatitis E | 2 | 2015 | 6 | 0.250 |
Why?
|
| Diet, Reducing | 1 | 2024 | 36 | 0.220 |
Why?
|
| Cytokines | 4 | 2015 | 625 | 0.220 |
Why?
|
| Colon | 1 | 2024 | 104 | 0.210 |
Why?
|
| Caseins | 1 | 2023 | 78 | 0.210 |
Why?
|
| C-Reactive Protein | 1 | 2023 | 155 | 0.190 |
Why?
|
| Liver | 2 | 2023 | 1159 | 0.180 |
Why?
|
| Interleukin-6 | 1 | 2023 | 278 | 0.180 |
Why?
|
| Food Quality | 1 | 2020 | 2 | 0.180 |
Why?
|
| Inflammation | 2 | 2024 | 642 | 0.180 |
Why?
|
| Body Weight | 1 | 2023 | 522 | 0.170 |
Why?
|
| Nutritional Sciences | 1 | 2020 | 31 | 0.170 |
Why?
|
| Hepatitis E virus | 2 | 2015 | 8 | 0.160 |
Why?
|
| Curriculum | 1 | 2020 | 399 | 0.140 |
Why?
|
| Chemokine CCL5 | 2 | 2007 | 9 | 0.130 |
Why?
|
| NF-kappa B | 2 | 2010 | 328 | 0.130 |
Why?
|
| Micronutrients | 1 | 2015 | 17 | 0.120 |
Why?
|
| Glutathione | 2 | 2007 | 306 | 0.120 |
Why?
|
| Arsenic | 1 | 2015 | 22 | 0.120 |
Why?
|
| Pregnancy Complications, Infectious | 1 | 2015 | 81 | 0.110 |
Why?
|
| Gene Expression | 2 | 2007 | 623 | 0.110 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2020 | 561 | 0.110 |
Why?
|
| Environmental Pollutants | 1 | 2015 | 106 | 0.110 |
Why?
|
| Cross-Sectional Studies | 3 | 2024 | 1676 | 0.100 |
Why?
|
| Immunophenotyping | 1 | 2012 | 117 | 0.100 |
Why?
|
| Coculture Techniques | 1 | 2012 | 145 | 0.100 |
Why?
|
| Lymphocyte Activation | 1 | 2012 | 172 | 0.090 |
Why?
|
| Hemorrhagic Fever with Renal Syndrome | 1 | 2011 | 1 | 0.090 |
Why?
|
| Amino Acid Motifs | 1 | 2011 | 59 | 0.090 |
Why?
|
| Alanine | 1 | 2011 | 44 | 0.090 |
Why?
|
| Mice, Inbred C57BL | 2 | 2007 | 1903 | 0.090 |
Why?
|
| Interferon-beta | 1 | 2011 | 33 | 0.090 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2012 | 165 | 0.090 |
Why?
|
| Dogs | 1 | 2011 | 183 | 0.090 |
Why?
|
| Protein Transport | 1 | 2011 | 183 | 0.090 |
Why?
|
| Antigen-Presenting Cells | 1 | 2010 | 23 | 0.080 |
Why?
|
| Cells, Cultured | 1 | 2012 | 1589 | 0.080 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2012 | 1552 | 0.080 |
Why?
|
| Cell Line | 1 | 2011 | 1045 | 0.070 |
Why?
|
| Risk Factors | 3 | 2024 | 3872 | 0.070 |
Why?
|
| Chemokine CCL4 | 1 | 2007 | 5 | 0.070 |
Why?
|
| Macrophage Inflammatory Proteins | 1 | 2007 | 5 | 0.070 |
Why?
|
| Chemokines, CC | 1 | 2007 | 9 | 0.070 |
Why?
|
| Glutathione Peroxidase | 1 | 2007 | 23 | 0.070 |
Why?
|
| Interleukin-4 | 1 | 2007 | 44 | 0.070 |
Why?
|
| Chemokine CCL3 | 1 | 2007 | 13 | 0.070 |
Why?
|
| Interleukin-2 | 1 | 2007 | 69 | 0.070 |
Why?
|
| Ascorbic Acid | 1 | 2006 | 25 | 0.070 |
Why?
|
| Sex Factors | 2 | 2024 | 727 | 0.070 |
Why?
|
| Chemokine CCL2 | 1 | 2006 | 69 | 0.060 |
Why?
|
| Virulence | 1 | 2007 | 167 | 0.060 |
Why?
|
| Interleukin-1 | 1 | 2006 | 108 | 0.060 |
Why?
|
| Mice | 2 | 2007 | 5965 | 0.060 |
Why?
|
| Bangladesh | 2 | 2015 | 26 | 0.060 |
Why?
|
| Humans | 8 | 2024 | 52336 | 0.060 |
Why?
|
| Oxidation-Reduction | 1 | 2006 | 328 | 0.060 |
Why?
|
| Survival Analysis | 1 | 2007 | 671 | 0.060 |
Why?
|
| Antibodies, Viral | 2 | 2015 | 110 | 0.060 |
Why?
|
| Adult | 5 | 2022 | 14139 | 0.060 |
Why?
|
| Kuwait | 1 | 2024 | 1 | 0.060 |
Why?
|
| Survival Rate | 1 | 2007 | 940 | 0.060 |
Why?
|
| Female | 6 | 2024 | 28105 | 0.050 |
Why?
|
| Mice, Knockout | 1 | 2006 | 909 | 0.050 |
Why?
|
| Child | 3 | 2024 | 7157 | 0.050 |
Why?
|
| RNA, Messenger | 1 | 2006 | 1142 | 0.050 |
Why?
|
| Lipoproteins, HDL | 1 | 2022 | 18 | 0.050 |
Why?
|
| Triglycerides | 1 | 2022 | 165 | 0.050 |
Why?
|
| Sex Characteristics | 1 | 2022 | 198 | 0.040 |
Why?
|
| Malawi | 1 | 2020 | 14 | 0.040 |
Why?
|
| Accreditation | 1 | 2020 | 62 | 0.040 |
Why?
|
| Faculty | 1 | 2020 | 74 | 0.040 |
Why?
|
| Nutrition Assessment | 1 | 2020 | 66 | 0.040 |
Why?
|
| Overweight | 1 | 2022 | 224 | 0.040 |
Why?
|
| Young Adult | 3 | 2015 | 4319 | 0.040 |
Why?
|
| Chi-Square Distribution | 1 | 2020 | 288 | 0.040 |
Why?
|
| Diet | 1 | 2024 | 588 | 0.040 |
Why?
|
| Universities | 1 | 2020 | 175 | 0.040 |
Why?
|
| Exercise | 1 | 2024 | 548 | 0.040 |
Why?
|
| Prevalence | 1 | 2022 | 1007 | 0.040 |
Why?
|
| Adolescent | 3 | 2015 | 6692 | 0.040 |
Why?
|
| Pregnancy | 2 | 2015 | 2675 | 0.040 |
Why?
|
| Pregnancy Trimester, First | 1 | 2015 | 23 | 0.030 |
Why?
|
| Pregnancy Trimester, Third | 1 | 2015 | 57 | 0.030 |
Why?
|
| Disease Susceptibility | 1 | 2015 | 96 | 0.030 |
Why?
|
| Postpartum Period | 1 | 2015 | 109 | 0.030 |
Why?
|
| Immunoglobulin G | 1 | 2015 | 195 | 0.030 |
Why?
|
| Environmental Exposure | 1 | 2015 | 216 | 0.030 |
Why?
|
| Case-Control Studies | 1 | 2015 | 1201 | 0.020 |
Why?
|
| Geography | 1 | 2011 | 66 | 0.020 |
Why?
|
| Middle Aged | 2 | 2020 | 13014 | 0.020 |
Why?
|
| China | 1 | 2011 | 134 | 0.020 |
Why?
|
| Rural Population | 1 | 2015 | 572 | 0.020 |
Why?
|
| Gene Expression Regulation | 1 | 2015 | 1006 | 0.020 |
Why?
|
| Mortality | 1 | 2011 | 104 | 0.020 |
Why?
|
| Hantavirus Infections | 1 | 2010 | 1 | 0.020 |
Why?
|
| Poly I-C | 1 | 2010 | 6 | 0.020 |
Why?
|
| Rats, Inbred Lew | 1 | 2010 | 48 | 0.020 |
Why?
|
| Toll-Like Receptors | 1 | 2010 | 27 | 0.020 |
Why?
|
| Ligands | 1 | 2010 | 207 | 0.020 |
Why?
|
| Dendritic Cells | 1 | 2010 | 136 | 0.020 |
Why?
|
| Host-Pathogen Interactions | 1 | 2010 | 144 | 0.020 |
Why?
|
| Incidence | 1 | 2011 | 1059 | 0.020 |
Why?
|
| Macrophages | 1 | 2010 | 378 | 0.020 |
Why?
|
| Cell Differentiation | 1 | 2010 | 674 | 0.020 |
Why?
|
| Aged | 1 | 2020 | 10109 | 0.020 |
Why?
|
| Child, Preschool | 1 | 2011 | 4030 | 0.010 |
Why?
|